Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01976247 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction
A Phase 1 study of Abdominal Fat, sponsored by Northwestern University.
- Active
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT01976247 is a Phase 1 study of Abdominal Fat that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01976247, a Phase 1 study of Abdominal Fat, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the safety and effectiveness of the Zeltiq System and LipoSonix System for fat reduction and improving body shape.
Conditions Studied
Interventions
- DEVICE High Intensity Focused Ultrasound Device
- DEVICE Noninvasive Cryolipolysis Device
Study Locations (1)
Illinois
- Northwestern University Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-10 |
| Est. Completion | 2025-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01976247
The ClinicalTrials.gov registry entry for NCT01976247 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Fat appearing as the primary indexed condition, and to 2 interventions - of which High Intensity Focused Ultrasound Device is the first listed.
NCT01976247 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01976247 about?
NCT01976247 is a clinical study titled "A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction". The purpose of this study is to compare the safety and effectiveness of the Zeltiq System and LipoSonix System for fat reduction and improving body shape.
What is the current status of trial NCT01976247?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2013-10. Estimated completion is 2025-12.
What conditions does trial NCT01976247 study?
This clinical trial studies the following conditions: Abdominal Fat.
What interventions are being tested in trial NCT01976247?
The interventions under investigation include: High Intensity Focused Ultrasound Device (DEVICE), Noninvasive Cryolipolysis Device (DEVICE).
Who is sponsoring clinical trial NCT01976247?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01976247 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Fat
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.